Pharmabiz

Japan MHLW grants orphan drug designation to GSK’s B7-H3-targeted antibody-drug conjugate, risvutatug rezetecan to treat small-cell lung cancer

Japan MHLW grants orphan drug designation to GSK’s B7-H3-targeted antibody-drug conjugate, risvutatug rezetecan to treat small-cell lung cancer: London, UK Tuesday, March 24, 20 ...
Pharmabiz

India needs to put in place strategic measures to combat spurious drugs: Dr BR Jagashetty

India needs to put in place strategic measures to combat spurious drugs: Dr BR Jagashetty: Nandita Vijayasimha, Bengaluru Tuesday, March 24, 2026, 08:00 Hrs [IST] India urgently n ...
Pharmabiz

FIPO joins national protests against proposed amendments to Drugs and Cosmetics Rules

FIPO joins national protests against proposed amendments to Drugs and Cosmetics Rules: Peethaambaran Kunnathoor, Chennai Tuesday, March 24, 2026, 08:00 Hrs [IST] The Federation of ...
Pharmabiz

AiMeD seeks govt support to overcome challenges arising from Middle East conflict

AiMeD seeks govt support to overcome challenges arising from Middle East conflict: Our Bureau, New Delhi Tuesday, March 24, ...
Pharmabiz

Strong govt policy & entrepreneurial drive make advanced medical devices accessible: Prashant Krishnan

Strong govt policy & entrepreneurial drive make advanced medical devices accessible: Prashant Krishnan: Shardul Nautiyal, Mumbai Tuesday, March 24, 2026, 08:00 Hrs [IST] Strong go ...
Pharmabiz

AIOCD moves to end TNCDA crisis, ODC to decide on Selvan’s expulsion

AIOCD moves to end TNCDA crisis, ODC to decide on Selvan’s expulsion: Peethaambaran Kunnathoor, Chennai Tuesday, March 24, 2026, 08:00 Hrs [IST] The Tamil Nadu Chemists and Drug ...
Pharmabiz

Parliamentary Panel asks DoP to take corrective steps to remove delays in PRIP

Parliamentary Panel asks DoP to take corrective steps to remove delays in PRIP: Gireesh Babu, New Delhi Tuesday, March 24, 2026, 08:00 Hrs [IST] The Parliamentary Panel on Chemica ...
Pharmabiz

Arch Biopartners announces SM begins patient dosing in phase II CS-AKI trial of LSALT peptide

Arch Biopartners announces SM begins patient dosing in phase II CS-AKI trial of LSALT peptide: Toronto Monday, March 23, 2026, 18:00 Hrs [IST] Arch Biopartners Inc. (Arch) announc ...
Pharmabiz

Caris Life Sciences reports another breakthrough study for GPSai in identifying and correcting misdiagnosis of cancer patients

Caris Life Sciences reports another breakthrough study for GPSai in identifying and correcting misdiagnosis of cancer patients: Irving, Texas Monday, March 23, 2026, 16:00 Hrs [IS ...
Pharmabiz

Trivitron launches Kiran Smart Track, a first-of-its-kind app in India for radiation protection apparel monitoring

Trivitron launches Kiran Smart Track, a first-of-its-kind app in India for radiation protection apparel monitoring: Our Bureau, Bengaluru Monday, March 23, 2026, 16:45 Hrs [IST] T ...
Pharmabiz

Bristol Myers Squibb transforms the classical Hodgkin lymphoma treatment paradigm with expanded US & EMA approvals for Opdivo

Bristol Myers Squibb transforms the classical Hodgkin lymphoma treatment paradigm with expanded US & EMA approvals for Opdivo: Princeton, New Jersey Monday, March 23, 2026, 17:00 ...
Pharmabiz

US FDA schedules public meeting on the Commissioner’s National Priority Voucher pilot programme

As part of the US Food and Drug Administration’s continuous quality improvement efforts, the agency published a Federal Register Notice seeking public comment on the Commissioner’s National Priority ...